Resultados de la búsqueda 71-80 of 4580 for peptides

  1. Mayo Clinic Physician Update - July 2024

    Page 1.

  2. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    ... peptide receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Given the restricted expression profile, FAP is a promising target for peptide-targeted radionuclide imaging and therapeutic agents. Phase 1 of this study ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Given the restricted expression profile, FAP is a promising target for peptide-targeted radionuclide imaging and therapeutic agents. Phase 1 of this study ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic ...

  6. Ensayos clínicos - Centro Pediátrico de Mayo Clinic - Centro Pediátrico de Mayo Clinic

    90 genes related to Monogenic Stone Disease will be determined via DNA analysis by the Mayo Rare Kidney Stone Consortium (RKSC) research staff. Dabrafenib ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or ...

  8. Medicamentos para la diabetes y pérdida de peso - Mayo Clinic

    Glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus. https://www.uptodate.com/contents/search. Accessed Oct. 24, 2024 ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... peptide receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous ...